Table of Contents
<< Previous Issue | Nov 2022 (Vol: 2022, Issue: 11) | Next Issue >> |
- Section: Licensing
-
Hookipa Pharma signs US$958 M Deal with Roche to develop HB-700 for KRAS-mutated Cancers
-
Astellas Turns to AAV-based Gene Therapy with Taysha Gene Therapies Collaboration Deal
- Section: Mergers & Acquisitions
-
J&J to Acquire Abiomed for US$16.6 B
-
Merck & Co. Acquires Imago BioSciences for US$1.35 B
- Section: Opinion & Analysis
-
Busy Start to Q4 in M&A Deal Making
- Section: Research & Development
-
Sanofi and miRecule Partner to Develop Novel Antibody-RNA Conjugate for Muscular Dystrophy Therapy
-
Sanofi Signs US$1.2 B AI Drug Discovery Deal with Insilico Medicine
-
Regeneron Collaborates with CytomX in Bispecific Cancer Deal